Dr. Raza Khan, MD
Claim this profileAultman Health Foundation
Area of expertise
Lung Cancer
Raza Khan, MD has run 12 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Raza Khan, MD has run 9 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Aultman Health Foundation
Aultman Alliance Community Hospital
Clinical Trials Raza Khan, MD is currently running
Observation
for Non-Small Cell Lung Cancer
GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.
Recruiting
1 award
N/A
10 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
More about Raza Khan, MD
Clinical Trial Related
11 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Raza Khan, MD has experience with
- Carboplatin
- Pembrolizumab
- Paclitaxel
- Pemetrexed
- Nab-paclitaxel
- Atezolizumab
Breakdown of trials Raza Khan, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Colon Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raza Khan, MD specialize in?
Raza Khan, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Raza Khan, MD currently recruiting for clinical trials?
Yes, Raza Khan, MD is currently recruiting for 8 clinical trials in Canton Ohio. If you're interested in participating, you should apply.
Are there any treatments that Raza Khan, MD has studied deeply?
Yes, Raza Khan, MD has studied treatments such as Carboplatin, Pembrolizumab, Paclitaxel.
What is the best way to schedule an appointment with Raza Khan, MD?
Apply for one of the trials that Raza Khan, MD is conducting.
What is the office address of Raza Khan, MD?
The office of Raza Khan, MD is located at: Aultman Health Foundation, Canton, Ohio 44710 United States. This is the address for their practice at the Aultman Health Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.